These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23956210)

  • 1. Macrophage microRNA-155 promotes cardiac hypertrophy and failure.
    Heymans S; Corsten MF; Verhesen W; Carai P; van Leeuwen RE; Custers K; Peters T; Hazebroek M; Stöger L; Wijnands E; Janssen BJ; Creemers EE; Pinto YM; Grimm D; Schürmann N; Vigorito E; Thum T; Stassen F; Yin X; Mayr M; de Windt LJ; Lutgens E; Wouters K; de Winther MP; Zacchigna S; Giacca M; van Bilsen M; Papageorgiou AP; Schroen B
    Circulation; 2013 Sep; 128(13):1420-32. PubMed ID: 23956210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling.
    Koren L; Alishekevitz D; Elhanani O; Nevelsky A; Hai T; Kehat I; Shaked Y; Aronheim A
    Int J Cardiol; 2015 Nov; 198():232-40. PubMed ID: 26201690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Heggermont WA; Papageorgiou AP; Quaegebeur A; Deckx S; Carai P; Verhesen W; Eelen G; Schoors S; van Leeuwen R; Alekseev S; Elzenaar I; Vinckier S; Pokreisz P; Walravens AS; Gijsbers R; Van Den Haute C; Nickel A; Schroen B; van Bilsen M; Janssens S; Maack C; Pinto Y; Carmeliet P; Heymans S
    Circulation; 2017 Aug; 136(8):747-761. PubMed ID: 28611091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
    J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155 inhibition attenuates endoplasmic reticulum stress-induced cardiomyocyte apoptosis following myocardial infarction via reducing macrophage inflammation.
    Hu J; Huang CX; Rao PP; Cao GQ; Zhang Y; Zhou JP; Zhu LY; Liu MX; Zhang GG
    Eur J Pharmacol; 2019 Aug; 857():172449. PubMed ID: 31207208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
    Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
    Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
    Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
    Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes Derived From Hypertrophic Cardiomyocytes Induce Inflammation in Macrophages
    Yu H; Qin L; Peng Y; Bai W; Wang Z
    Front Immunol; 2020; 11():606045. PubMed ID: 33613526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation.
    Ren J; Avery J; Zhao H; Schneider JG; Ross FP; Muslin AJ
    J Mol Cell Cardiol; 2007 Feb; 42(2):367-77. PubMed ID: 17184791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure.
    Marques FZ; Prestes PR; Byars SG; Ritchie SC; Würtz P; Patel SK; Booth SA; Rana I; Minoda Y; Berzins SP; Curl CL; Bell JR; Wai B; Srivastava PM; Kangas AJ; Soininen P; Ruohonen S; Kähönen M; Lehtimäki T; Raitoharju E; Havulinna A; Perola M; Raitakari O; Salomaa V; Ala-Korpela M; Kettunen J; McGlynn M; Kelly J; Wlodek ME; Lewandowski PA; Delbridge LM; Burrell LM; Inouye M; Harrap SB; Charchar FJ
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28615213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy.
    Pavelec CM; Young AP; Luviano HL; Orrell EE; Szagdaj A; Poudel N; Wolpe AG; Thomas SH; Yeudall S; Upchurch CM; Okusa MD; Isakson BE; Wolf MJ; Leitinger N
    Circ Res; 2024 Aug; 135(4):503-517. PubMed ID: 38957990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
    Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
    Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy.
    Li PL; Liu H; Chen GP; Li L; Shi HJ; Nie HY; Liu Z; Hu YF; Yang J; Zhang P; Zhang XJ; She ZG; Li H; Huang Z; Zhu L
    Hypertension; 2020 Oct; 76(4):1219-1230. PubMed ID: 32862709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
    Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
    J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.